|
Source – The Food and Drug Administration – The Food and Drug Administration (FDA) has approved Daytrana, the first transdermal patch containing methylphenidate, to treat Attention Deficit Hyperactivity Disorder (ADHD) in children 6 to 12 years of age.
Daytrana should be applied each morning to the alternating hip and worn for nine hours.
Daytrana is not licensed in the United Kingdom
For more information go to: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01352.html
Prepared by Susan Wileman Medicines Information Technician
Date of Preparation: 11th April 2006
|
